The global pharmaceutical glass packaging market size is expected to reach USD 37.62 billion by 2030, registering a CAGR of 9.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The factors expected to drive the growth are the high recyclability of the glass, chemical inertness, increasing developments in the pharmaceutical industry, and the growing demand for vials for COVID vaccines.
The pharmaceutical industry is witnessing a significant transition and over the past few years, the focus on the development of pharmaceutical drugs has grown significantly. The growing research environment in emerging economies such as India, China, and Brazil has led to a gradual migration of economic and research activities from developed markets to these emerging markets. Since 2006, the United Nations Industrial Development Organization has provided advisory services and technical cooperation to develop local pharmaceutical production in developing countries. This promises to boost the pharmaceutical sector in these countries thereby driving the pharmaceutical plastic packaging industry.
Gather more insights about the market drivers, restrains and growth of the Pharmaceutical Glass Packaging Market
However, the pharmaceutical glass packaging industry is expected to witness some challenges in the forthcoming years since glass is an expensive raw material. Plastic bottles are being used for pharma packaging which is made of lightweight, clear, and durable plastic belonging to the polyester family. Furthermore, developments are being carried out to develop material that overcomes the shortcomings of glass and plastic which can negatively impact the pharmaceutical glass packaging industry. For instance, in May 2022, Mitsubishi Gas Chemical Company, Inc. and BD (Becton, Dickinson and Company) agreed to develop Oxycapt, a multilayer material integrating features of plastic and glass for prefilled syringes.
Pharmaceutical-grade silicone-based fluids are being extensively applied on the inner surface of glass vials and ampoules to allow the draining of vaccines from the glass packaging products and maintain the efficacy and safety of Active Pharmaceutical Ingredients (APIs). In January 2022, West Pharmaceutical Services, Inc. entered into a technology and supply agreement with Corning Incorporated to expand Valor Glass technology for developing advanced injectable drug packaging and delivery systems.
Pharmaceutical Glass Packaging Market Report Highlights
The generic drug type led the market and accounted for more than 72.9% share of the global revenue in 2023. The main factor contributing to their market growth is pricing and often the shortage of an established pharmaceutical product in the market. Most generic medicines tend to cost less than their brand-name counterparts and provide effective results similar to their brand-name counterpartsAtmospheric emissions are caused by the melting of raw materials and combustion of natural gas in glass production. The negative environmental impact is expected to drive pharmaceutical glass manufacturers to develop sustainable glass production processes. For instance, in November 2021, Bormioli Pharma S.p.A. inked a 10-year agreement with Glass Futures to jointly carry out research and development of new low-emission technologies for glass productionGlass delamination has been a major concern for pharmaceutical companies. It includes the appearance of glass lamellae or visible flakes which can lead to an increased number of recalls and health risks. The development of glass vials by reducing the alkali content reduces the chances of delamination and breakage. Furthermore, pharmaceutical glass packaging is manufactured by molded processes offering greater design flexibility and high mechanical resistance which reduces the breakage riskIn May 2021, Nipro Europe Group Companies acquired Piramida, a Croatian pharmaceutical glass packaging manufacturer to strengthen its presence in Central EuropeCompanies in the pharmaceutical glass packaging industry are trying to increase their production capacity to cater to the growing pharmaceutical requirement. In October 2022, SCHOTT Group announced that it began construction of a new pre-fillable glass syringe (PFS) production facility inLukácsháza, HungaryBrowse more reports published by Grand View Research.
Energy Retrofit Systems Market Size, Share & Trends Analysis Report By Product (Envelope, LED Retrofit Lighting), By Application (Residential, Commercial, Institutional), By Region, And Segment Forecasts, 2024 - 2030Phosphoric Acid Fuel Cell Market Size, Share & Trends Analysis Report By Application (Vehicles, Cogeneration, Others), By Region (North America, Europe, Asia Pacific, Middle East & Africa), And Segment Forecasts, 2024 - 2030List of Key Players in the Pharmaceutical Glass Packaging Market
Corning IncorporatedNipro CorporationSGD S.A.Stoelzle Oberglas GmbHBormioli Pharma S.p.A.West Pharmaceutical Services, Inc.Schott AGGerresheimer AGShandong Medicinal Glass Co., Ltd.Beatson ClarkArdagh Group S.AArab Pharmaceutical Glass Co.Piramal Enterprises Ltd.Şişecam GroupOwens-Illinois, Inc.DWK Life sciencesAbout Grand View Research
Grand View Research is a full-time market research and consulting company registered in San Francisco, California. The company fully offers market reports, both customized and syndicates, based on intense data analysis. It also offers consulting services to business communities and academic institutions and helps them understand the global and business scenario to a significant extent. The company operates across multitude of domains such as Chemicals, Materials, Food and Beverages, Consumer Goods, Healthcare, and Information Technology to offer consulting services.
Explore Horizon, the world's most expansive market research database
